Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Vizsgálati helyszín

Tandem Clinical Research

Marrero, Louisiana 70072, Egyesült ÁllamokMég nincs intézményhez kötve

22futó vizsgálat
25lezárt vizsgálat

Az itteni vizsgálatok

Miről szól a helyszín 47 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek: Zsírmáj (MASLD/MASH)14 vizsgálat
Elhízás8 vizsgálat
Liver cirrhosis5 vizsgálat
2-es típusú cukorbetegség4 vizsgálat
Crohn-betegség3 vizsgálat
Depresszió3 vizsgálat
Osteoarthritis3 vizsgálat
Familiáris hiperkoleszterinémia2 vizsgálat
Gastroparesis2 vizsgálat
1-es típusú cukorbetegség1 vizsgálat
Alzheimer-kór1 vizsgálat
Coeliac disease1 vizsgálat
és még 10
Fázis: 2. fázis22 vizsgálat
3. fázis17 vizsgálat
1. fázis2 vizsgálat
1/2. fázis2 vizsgálat
2/3. fázis2 vizsgálat
4. fázis1 vizsgálat
Állapot: Lezárult22 vizsgálat
Fut, nem toboroz13 vizsgálat
Toboroz7 vizsgálat
Még nem toboroz2 vizsgálat
Leállították2 vizsgálat
Visszavonták1 vizsgálat
Fő szponzor: Eli Lilly and Company6 vizsgálat
Janssen Research & Development, LLC5 vizsgálat
Boehringer Ingelheim4 vizsgálat
Regeneron Pharmaceuticals4 vizsgálat
CinDome Pharma, Inc.2 vizsgálat
és még 24

Futó vizsgálatok

Toboroz
Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
NCT07854782· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
NCT07881458· 3. fázis· Eli Lilly and Company· Forrás
Contact: Adil Fatakia (principal investigator)
Toboroz
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
NCT07635563· 2. fázis· Incannex Healthcare Ltd· Forrás
Contact: Courtney Hargrove
Toboroz
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
NCT07631637· 2. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
NCT07477704· 2. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
NCT07165028· 3. fázis· Eli Lilly and Company· Forrás
Contact: Gary Reiss (principal investigator)
Toboroz
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
NCT06653153· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
NCT05979779· 2. fázis· Rivus Pharmaceuticals, Inc.· Forrás
Fut, nem toboroz
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
NCT05672576· 3. fázis· Viatris Innovation GmbH· Forrás
Toboroz
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
NCT05648214· 1/2. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
NCT05500222· 3. fázis· Madrigal Pharmaceuticals, Inc.· Forrás
Fut, nem toboroz
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
NCT05242471· 2. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
NCT05197049· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
NCT05490888· 1. fázis· PharmaIN· Forrás
Contact: Alexis Johnson
Fut, nem toboroz
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
NCT04809376· 2/3. fázis· Paradigm Biopharmaceuticals USA (INC)· Forrás
Fut, nem toboroz
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
NCT04849728· 3. fázis· Inventiva Pharma· Forrás
Fut, nem toboroz
Eversense® Non-adjunctive Use Post Approval Study
NCT04836546· Senseonics, Inc.· Forrás
Fut, nem toboroz
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
NCT04822181· 3. fázis· Novo Nordisk A/S· Forrás
Fut, nem toboroz
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
NCT03900429· 3. fázis· Madrigal Pharmaceuticals, Inc.· Forrás
Fut, nem toboroz
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411· 2/3. fázis· Janssen Research & Development, LLC· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Lezárt vizsgálatok

Toboroz
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397· 3. fázis· Cybin IRL Limited· Forrás
Contact: Clinical Development
Lezárult
GV101 in Healthy Obese Participants
NCT06979505· 2. fázis· Graviton Bioscience Corporation· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
NCT06899217· 2. fázis· CinDome Pharma, Inc.· Forrás
Lezárult
A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity
NCT06259981· 2. fázis· Glyscend, Inc.· Forrás
Lezárult
A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain
NCT06379893· 4. fázis· HALEON· Forrás
Lezárult
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
NCT06373146· 2. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
NCT06254612· 2. fázis· Sirtsei Pharmaceuticals, Inc.· Forrás
Lezárult
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
NCT06192108· 3. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
NCT06077864· 3. fázis· Boehringer Ingelheim· Forrás
Lezárult
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06049017· 2. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
NCT05552755· 1/2. fázis· Recursion Pharmaceuticals Inc.· Forrás
Contact: Recursion Pharmaceuticals
Lezárult
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
NCT05774184· 2. fázis· Celldex Therapeutics· Forrás
Lezárult
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
NCT05869669· 2. fázis· EIP Pharma Inc· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
NCT05832151· 2. fázis· CinDome Pharma, Inc.· Forrás
Lezárult
HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes
NCT05623189· 2. fázis· HighTide Therapeutics (Hong Kong) Limited· Forrás
Lezárult
A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
NCT05550532· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15
NCT05546476· 2. fázis· Pfizer· Forrás
Lezárult
Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
NCT05425446· 1. fázis· Chugai Pharmaceutical· Forrás
Lezárult
Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies
NCT05142722· 3. fázis· NewAmsterdam Pharma· Forrás
Lezárult
A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension
NCT04880031· 2. fázis· GlaxoSmithKline· Forrás
Lezárult
Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)
NCT05016882· 2. fázis· Novo Nordisk A/S· Forrás
Leállították
Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis
NCT04864392· 2. fázis· Novartis Pharmaceuticals· Forrás
Lezárult
A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
NCT04771273· 2. fázis· Boehringer Ingelheim· Forrás
Lezárult
Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
NCT04845178· 2. fázis· AEON Biopharma, Inc.· Forrás
Lezárult
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
NCT04166773· 2. fázis· Eli Lilly and Company· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 15.